Abstract:Background: Coronary stenosis severity determines ischemic symptoms and adverse outcomes. The metabolomic analysis of human fluids can provide an insight into the pathogenesis of complex disease. Thus, this study aims to investigate the metabolomic and lipidomic biomarkers of coronary artery disease (CAD) severity and to develop diagnostic models for distinguishing individuals at an increased risk of atherosclerotic burden and plaque instability. Methods: Widely targeted metabolomic and lipidomic analyses of plasma in 1,435 CAD patients from three independent centers were performed. These patients were classified as stable coronary artery disease (SCAD), unstable angina (UA), and myocardial infarction (MI). Associations between CAD stages and metabolic conditions were assessed by multivariable-adjusted logistic regression. Furthermore, the least absolute shrinkage and selection operator logistic-based classifiers were used to identify biomarkers and to develop prediagnostic models for discriminating the diverse CAD stages. Results: On the basis of weighted correlation network analysis, 10 co-clustering metabolite modules significantly ( p < 0.05) changed at different CAD stages and showed apparent correlation with CAD severity indicators. Moreover, cross-comparisons within CAD patients characterized that a total of 72 and 88 metabolites/lipid species significantly associated with UA (vs. SCAD) and MI (vs. UA), respectively. The disturbed pathways included glycerophospholipid metabolism, and cysteine and methionine metabolism. Furthermore, models incorporating metabolic and lipidomic profiles with traditional risk factors were constructed. The combined model that incorporated 11 metabolites/lipid species and four traditional risk factors represented better discrimination of UA and MI (C-statistic = 0.823, 95% CI, 0.783–0.863) compared with the model involving risk factors alone (C-statistic = 0.758, 95% CI, 0.712–0.810). The combined model was successfully used in discriminating UA and MI patients ( p < 0.001) in a three-center validation cohort. Conclusion: Differences in metabolic profiles of diverse CAD subtypes provided a new approach for the risk stratification of unstable plaque and the pathogenesis decipherment of CAD progression.

Optimum Subset Approach for Automatically Finding Effective Risk Markers in Coronary Artery Diseases

Prediction of presence and severity of coronary artery disease using prediction for atherosclerotic cardiovascular disease risk in China scoring system

Metabolomic Profile for the Early Detection of Coronary Artery Disease by Using UPLC-QTOF/MS.

Development of Machine Learning Tools for Predicting Coronary Artery Disease in the Chinese Population.

Exploring the Utility of the Reynolds and Framingham Risk Stratification Models in Predicting the Presence and Severity of Coronary Artery Disease in Chinese Patients

Low-Density Lipoprotein Cholesterol 4: The Notable Risk Factor of Coronary Artery Disease Development

A Novel Laboratory-Based Model to Predict the Presence of Obstructive Coronary Artery Disease.

Lipidomic-Based Algorithms Can Enhance Prediction of Obstructive Coronary Artery Disease

Application of Serum Protein Fingerprint in Diagnosis of Coronary Artery Disease

Development and Validation of a Predictive Model for Coronary Artery Disease Using Machine Learning

Construction and Validation of a Predictive Model for Coronary Artery Disease Using Extreme Gradient Boosting

Safety Evaluation and Effect Deconstruction of Blood Lipid Test in the Diagnosis of Cardiovascular Disease Patients

[A pretest model of obstructive coronary artery disease based on machine learning: from the C-Strat study]

Predictive effect of different blood lipid parameters combined with carotid intima-media thickness on coronary artery disease

Development and validation of a model integrating clinical and coronary lesion-based functional assessment for long-term risk prediction in PCI patients

Multimarker Approach For The Prediction Of Cardiovascular Events In Patients With Mild To Moderate Coronary Artery Lesions A 3-Year Follow-Up Study

The predictive value of coronary artery calcium score combined with traditional risk factors for obstructive coronary heart disease in young people

Multiple Biomarkers in the Context of Conventional Risk Factors in Patients With Coronary Artery Disease

Age-Biomarkers-Clinical Risk Factors for Prediction of Cardiovascular Events in Patients With Coronary Artery Disease

Comprehensive Metabolomics Identified the Prominent Role of Glycerophospholipid Metabolism in Coronary Artery Disease Progression

Prediction of the Risk of Mortality Using Risk Score in Patients with Coronary Heart Disease